vs

Side-by-side financial comparison of CSW INDUSTRIALS, INC. (CSW) and Oncology Institute, Inc. (TOI). Click either name above to swap in a different company.

CSW INDUSTRIALS, INC. is the larger business by last-quarter revenue ($233.0M vs $142.0M, roughly 1.6× Oncology Institute, Inc.). CSW INDUSTRIALS, INC. runs the higher net margin — 4.4% vs -5.3%, a 9.7% gap on every dollar of revenue. On growth, Oncology Institute, Inc. posted the faster year-over-year revenue change (41.6% vs 20.3%). CSW INDUSTRIALS, INC. produced more free cash flow last quarter ($22.7M vs $2.2M). Over the past eight quarters, Oncology Institute, Inc.'s revenue compounded faster (22.5% CAGR vs 5.1%).

Oncology Institute, Inc. is a specialized healthcare enterprise focused on delivering patient-centric, evidence-based oncology care services, including advanced treatment regimens, clinical trial access, and supportive care programs. It primarily operates across the United States, serving patients with diverse cancer diagnoses and partnering with care teams to improve treatment outcomes.

CSW vs TOI — Head-to-Head

Bigger by revenue
CSW
CSW
1.6× larger
CSW
$233.0M
$142.0M
TOI
Growing faster (revenue YoY)
TOI
TOI
+21.3% gap
TOI
41.6%
20.3%
CSW
Higher net margin
CSW
CSW
9.7% more per $
CSW
4.4%
-5.3%
TOI
More free cash flow
CSW
CSW
$20.5M more FCF
CSW
$22.7M
$2.2M
TOI
Faster 2-yr revenue CAGR
TOI
TOI
Annualised
TOI
22.5%
5.1%
CSW

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CSW
CSW
TOI
TOI
Revenue
$233.0M
$142.0M
Net Profit
$10.3M
$-7.5M
Gross Margin
39.7%
Operating Margin
7.4%
-4.9%
Net Margin
4.4%
-5.3%
Revenue YoY
20.3%
41.6%
Net Profit YoY
-61.9%
43.0%
EPS (diluted)
$0.62
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSW
CSW
TOI
TOI
Q4 25
$233.0M
$142.0M
Q3 25
$277.0M
$136.6M
Q2 25
$263.6M
$119.8M
Q1 25
$230.5M
$104.4M
Q4 24
$193.6M
$100.3M
Q3 24
$227.9M
$99.9M
Q2 24
$226.2M
$98.6M
Q1 24
$210.9M
$94.7M
Net Profit
CSW
CSW
TOI
TOI
Q4 25
$10.3M
$-7.5M
Q3 25
$40.7M
$-16.5M
Q2 25
$40.9M
$-17.0M
Q1 25
$35.1M
$-19.6M
Q4 24
$26.9M
$-13.2M
Q3 24
$36.1M
$-16.1M
Q2 24
$38.6M
$-15.5M
Q1 24
$31.8M
$-19.9M
Gross Margin
CSW
CSW
TOI
TOI
Q4 25
39.7%
Q3 25
43.0%
Q2 25
43.8%
Q1 25
44.2%
Q4 24
41.4%
Q3 24
45.6%
Q2 24
47.5%
Q1 24
44.4%
Operating Margin
CSW
CSW
TOI
TOI
Q4 25
7.4%
-4.9%
Q3 25
20.5%
-5.9%
Q2 25
20.8%
-9.4%
Q1 25
19.5%
-9.5%
Q4 24
15.3%
-11.9%
Q3 24
22.6%
-13.9%
Q2 24
24.3%
-16.6%
Q1 24
21.0%
-19.0%
Net Margin
CSW
CSW
TOI
TOI
Q4 25
4.4%
-5.3%
Q3 25
14.7%
-12.1%
Q2 25
15.5%
-14.2%
Q1 25
15.2%
-18.8%
Q4 24
13.9%
-13.1%
Q3 24
15.8%
-16.1%
Q2 24
17.1%
-15.7%
Q1 24
15.1%
-21.0%
EPS (diluted)
CSW
CSW
TOI
TOI
Q4 25
$0.62
$-0.04
Q3 25
$2.41
$-0.14
Q2 25
$2.43
$-0.15
Q1 25
$2.05
$-0.21
Q4 24
$1.60
$-0.14
Q3 24
$2.26
$-0.18
Q2 24
$2.47
$-0.17
Q1 24
$2.03
$-0.22

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSW
CSW
TOI
TOI
Cash + ST InvestmentsLiquidity on hand
$40.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.1B
$-15.7M
Total Assets
$2.3B
$164.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSW
CSW
TOI
TOI
Q4 25
$40.2M
Q3 25
$31.5M
Q2 25
$38.0M
Q1 25
$225.8M
Q4 24
$213.8M
Q3 24
$273.2M
Q2 24
$18.9M
$9.9M
Q1 24
$22.2M
$29.8M
Total Debt
CSW
CSW
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
$800.1M
Q4 24
Q3 24
Q2 24
Q1 24
$166.0M
Stockholders' Equity
CSW
CSW
TOI
TOI
Q4 25
$1.1B
$-15.7M
Q3 25
$1.1B
$-12.3M
Q2 25
$1.1B
$-9.0M
Q1 25
$1.1B
$5.1M
Q4 24
$1.0B
$3.6M
Q3 24
$1.0B
$15.5M
Q2 24
$650.2M
$29.2M
Q1 24
$615.7M
$41.3M
Total Assets
CSW
CSW
TOI
TOI
Q4 25
$2.3B
$164.7M
Q3 25
$1.5B
$163.6M
Q2 25
$1.5B
$159.8M
Q1 25
$1.4B
$164.0M
Q4 24
$1.4B
$172.7M
Q3 24
$1.4B
$179.2M
Q2 24
$1.1B
$179.6M
Q1 24
$1.0B
$204.5M
Debt / Equity
CSW
CSW
TOI
TOI
Q4 25
Q3 25
Q2 25
Q1 25
0.75×
Q4 24
Q3 24
Q2 24
Q1 24
0.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSW
CSW
TOI
TOI
Operating Cash FlowLast quarter
$28.9M
$3.2M
Free Cash FlowOCF − Capex
$22.7M
$2.2M
FCF MarginFCF / Revenue
9.8%
1.5%
Capex IntensityCapex / Revenue
2.6%
0.7%
Cash ConversionOCF / Net Profit
2.81×
TTM Free Cash FlowTrailing 4 quarters
$162.0M
$-27.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSW
CSW
TOI
TOI
Q4 25
$28.9M
$3.2M
Q3 25
$61.8M
$-12.6M
Q2 25
$60.6M
$-10.2M
Q1 25
$27.3M
$-5.0M
Q4 24
$11.6M
$4.2M
Q3 24
$66.8M
$819.0K
Q2 24
$62.7M
$-15.7M
Q1 24
$22.4M
$-15.9M
Free Cash Flow
CSW
CSW
TOI
TOI
Q4 25
$22.7M
$2.2M
Q3 25
$58.7M
$-13.2M
Q2 25
$57.7M
$-11.4M
Q1 25
$22.8M
$-5.3M
Q4 24
$8.5M
$2.4M
Q3 24
$61.3M
$417.0K
Q2 24
$59.6M
$-17.5M
Q1 24
$17.5M
$-16.5M
FCF Margin
CSW
CSW
TOI
TOI
Q4 25
9.8%
1.5%
Q3 25
21.2%
-9.7%
Q2 25
21.9%
-9.5%
Q1 25
9.9%
-5.1%
Q4 24
4.4%
2.4%
Q3 24
26.9%
0.4%
Q2 24
26.3%
-17.7%
Q1 24
8.3%
-17.4%
Capex Intensity
CSW
CSW
TOI
TOI
Q4 25
2.6%
0.7%
Q3 25
1.1%
0.4%
Q2 25
1.1%
1.0%
Q1 25
2.0%
0.3%
Q4 24
1.6%
1.8%
Q3 24
2.4%
0.4%
Q2 24
1.4%
1.9%
Q1 24
2.3%
0.6%
Cash Conversion
CSW
CSW
TOI
TOI
Q4 25
2.81×
Q3 25
1.52×
Q2 25
1.48×
Q1 25
0.78×
Q4 24
0.43×
Q3 24
1.85×
Q2 24
1.62×
Q1 24
0.71×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSW
CSW

Contractor Solutions Segment$166.3M71%
Specialized Reliability Solutions Segment$38.2M16%
Engineered Building Solutions Segment$28.5M12%

TOI
TOI

Other$82.1M58%
Fee For Service$36.3M26%
Capitated Revenue$23.6M17%

Related Comparisons